CTOs on the Move

Arrakis Therapeutics

www.arrakistx.com

 
Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly target RNA. Arrakis is building a proprietary pipeline of RNA-targeted small molecule (rSM) medicines focused on cancer and genetically validated targets in other disease areas. The company brings together scientific leaders in RNA structure, chemistry and biology, along with a highly experienced management team and the backing of leading life sciences investors. The company is located in Waltham, Massachusetts.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Jason Siglasky
Sr. Director, Head of Information Technology Profile

Funding

Arrakis Therapeutics raised $38M on 02/27/2017
Arrakis Therapeutics raised $75M on 04/18/2019

Similar Companies

Stonewood Village Pharmacy

Stonewood Village Pharmacy is a Fort Smith, AR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

International Partnership for Microbicides

Developing HIV prevention products for women worldwide

Honor Community Health

Honor Community Health (OIHN) is an HRSA-qualified community health center providing primary, behavioral health and dental care throughout Oakland County, Michigan.

AXXAM

AXXAM is a Milford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HEXO Corporation

HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, UP Cannabis, Original Stash, Bake Sale, Namaste, and REUP brands, and the medical market in Canada, Israel and Malta. The Company also serves the Colorado market through its Powered by HEXO® strategy and Truss CBD USA, a joint venture with Molson Coors. In the event that the previously announced transactions to acquire 48North and Redecan close, HEXO expects to be the number one cannabis products company in Canada by recreational market share.